Skip to main content

Advertisement

SpringerLink
Log in

A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme

  • Review
  • Published:
Biochemical Genetics Aims and scope Submit manuscript

Abstract

Pancreatic cancer (PC) and glioblastoma multiforme (GBM) are among the human cancers with worst prognosis which require an urgent need for efficient therapies. Here, we propose to apply to treat both malignancies with a triple combination of drugs, which are already in use for different indications. Recent studies demonstrated a considerable link between risk of PC and diabetes. In experimental models, anti-diabetogenic agents suppress growth of PC, including metformin (M), pioglitazone (P) and lithium (L). L is used in psychiatric practice, yet also bears anti-diabetic potential and selectively inhibits glycogen synthase kinase-3 beta (GSK-3β). M, a biguanide class anti-diabetic agent shows anticancer activity via activating AMP-activated protein kinase (AMPK). Glitazones bind to PPAR-γ and inhibit NF-κB, triggering cell proliferation, apoptosis resistance and synthesis of inflammatory cytokines in cancer cells. Inhibition of inflammatory cytokines could simultaneously decrease tumor growth and alleviate cancer cachexia, having a major role in PC mortality. Furthermore, mutual synergistic interactions exist between PPAR-γ and GSK-3β, between AMPK and GSK-3β and between AMPK and PPAR-γ. In GBM, M blocks angiogenesis and migration in experimental models. Very noteworthy, among GBM patients with type 2 diabetes, usage of M significantly correlates with better survival while reverse is true for sulfonylureas. In experimental models, P synergies with ligands of RAR, RXR and statins in reducing growth of GBM. Further, usage of P was found to be lesser in anaplastic astrocytoma and GBM patients, indicating a protective effect of P against high-grade gliomas. L is accumulated in GBM cells faster and higher than in neuroblastoma cells, and its levels further increase with chronic exposure. Recent studies revealed anti-invasive potential of L in GBM cell lines. Here, we propose that a triple-agent regime including drugs already in clinical usage may provide a metabolic adjuvant therapy for PC and GBM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adeberg S, Bernhardt D, Ben Harrabi S, Bostel T, Mohr A, Koelsche C, Diehl C, Rieken S, Debus J (2015) Metformin influences progression in diabetic glioblastoma patients. Strahlenther Onkol 191:928–935

    Article  PubMed  Google Scholar 

  • Adler JT, Hottinger DG, Kunnimalaiyaan M, Chen H (2010) Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride. J Surg Res 159:640–644

    Article  CAS  PubMed  Google Scholar 

  • Aggarwal G, Rabe KG, Pedersen GM, Chari ST (2012) New-onset diabetes in pancreatic cancer: a study in the primary care setting. Pancreatology 12:156–161

    Article  PubMed  PubMed Central  Google Scholar 

  • Ahren B, Andren-Sandberg A (1993) Glucose tolerance and insulin secretion in experimental pancreatic cancer in the Syrian hamster. Res Exp Med 193:21–26

    Article  CAS  Google Scholar 

  • Aldea MD, Petrushev B, Soritau O, Tomuleasa CI, Berindan-Neagoe I, Filip AG, Chereches G, Cenariu M, Craciun L, Tatomir C, Florian IS, Crivii CB, Kacso G (2014) Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells. J BUON 19:502–511

    PubMed  Google Scholar 

  • Azar M, Lyons TJ (2010) Diabetes, insulin treatment, and cancer risk: what is the evidence? F1000 Med Rep 24:2. doi:10.3410/M2-4

    Google Scholar 

  • Azimian-Zavareh V, Hossein G, Janzamin E (2012) Effect of lithium chloride and antineoplastic drugs on survival and cell cycle of androgen-dependent prostate cancer LNCap cells. Indian J Pharmacol 44:714–721

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME (2008) Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12:1193–1201

    Article  PubMed  Google Scholar 

  • Bachmann J, Ketterer K, Marsch C, Fechtner K, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME (2009) Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer 9:255

    Article  PubMed  PubMed Central  Google Scholar 

  • Ban JO, Kwak DH, Oh JH, Park EJ, Cho MC, Song HS, Song MJ, Han SB, Moon DC, Kang KW, Hong JT (2010) Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. Chem Biol Interact 188:75–85

    Article  CAS  PubMed  Google Scholar 

  • Ban JO, Oh JH, Son SM, Won D, Song HS, Han SB, Moon DC, Kang KW, Song MJ, Hong JT (2011) Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression. Cancer Biol Ther 12:288–296

    Article  CAS  PubMed  Google Scholar 

  • Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, Sarkar FH (2012) Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prev Res 5:355–364

    Article  CAS  Google Scholar 

  • Basso D, Greco E, Fogar P, Pucci P, Flagiello A, Baldo G, Giunco S, Valerio A, Navaglia F, Zambon CF et al (2006) Pancreatic cancer-derived S-100A8 N-terminal peptide: a diabetes cause? Clin Chim Acta 372:120–128

    Article  CAS  PubMed  Google Scholar 

  • Beckner ME, Gobbel GT, Abounader R, Burovic F, Agostino NR, Laterra J, Pollack IF (2005) Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis. Lab Investig 85:1457–1470

    Article  CAS  PubMed  Google Scholar 

  • Brentnall TA, Bronner MP, Byrd DR, Haggitt RC, Kimmey MB (1999) Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131:247–255

    Article  CAS  PubMed  Google Scholar 

  • Cai Z, Li B, Li K, Zhao B (2012) Down-regulation of amyloid-β through AMPK activation by inhibitors of GSK-3β in SH-SY5Y and SH-SY5Y-AβPP695 cells. J Alzheimers Dis 29:89–98

    CAS  PubMed  Google Scholar 

  • Cao Q, Lu X, Feng YJ (2006) Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells. Cell Res 16:671–677

    Article  CAS  PubMed  Google Scholar 

  • Carmignani M, Volpe AR, Aldea M, Soritau O, Irimie A, Florian IS, Tomuleasa C, Baritchii A, Petrushev B, Crisan G, Valle G (2014) Glioblastoma stem cells: a new target for metformin and arsenic trioxide. J Biol Regul Homeost Agents 28(1):1–15

    CAS  PubMed  Google Scholar 

  • Chari ST, Leibson CL, Rabe KG, Ransom J, de Andrade M, Petersen GM (2005) A probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129:504–511

    Article  PubMed  PubMed Central  Google Scholar 

  • Chari ST, Leibson CL, Rabe KG, Timmons LJ, Ransom J, de Andrade M, Petersen GM (2008) Pancreatic cancer associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134:95–101

    Article  CAS  PubMed  Google Scholar 

  • Chen X, McMahon EG, Gulve EA (1998) Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP1. Am J Physiol 275(2 Pt 1):E272–E277

    CAS  PubMed  Google Scholar 

  • Chen D, Banerjee S, Cui QC, Kong D, Sarkar FH, Dou QP (2012a) Activation of AMP activated protein kinase by 3,3′-diindolylmethane (DIM) is associated with human prostate cancer cell death in vitro and in vivo. PLoS One 7:e47186

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen D, Pamu S, Cui Q, Chan TH, Dou QP (2012b) Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells. Bioorg Med Chem 20:3031–3037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen Z, Zhang L, Yi J, Yang Z, Zhang Z, Li Z (2012c) Promotion of adiponectin multimerization by emodin: a novel AMPK activator with PPARγ-agonist activity. J Cell Biochem 113:3547–3558

    Article  CAS  PubMed  Google Scholar 

  • Chiang MC, Cheng YC, Lin KH, Yen CH (2013) PPARγ regulates the mitochondrial dysfunction in human neural stem cells with tumor necrosis factor alpha. Neuroscience 229:118–129

    Article  CAS  PubMed  Google Scholar 

  • Chintharlapalli S, Papineni S, Liu S, Jutooru I, Chadalapaka G, Cho SD, Murthy RS, You Y, Safe S (2007) 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells. Carcinogenesis 28:2337–2346

    Article  CAS  PubMed  Google Scholar 

  • Cho N, Momose Y (2008) Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress. Curr Top Med Chem 8:1483–1507

    Article  CAS  PubMed  Google Scholar 

  • Cho SY, Lee HJ, Lee HJ, Jung DB, Kim H, Sohn EJ, Kim B, Jung JH, Kwon BM, Kim SH (2013) Activation of AMP-activated protein kinase α and extracelluar signal-regulated kinase mediates CB-PIC-induced apoptosis in hypoxic SW620 colorectal cancer cells. Evid Based Complement Alternat Med 2013:974313

    PubMed  PubMed Central  Google Scholar 

  • Cooperman AM, Chivati J, Chamberlain RS (2000) Nutritional and metabolic aspects of pancreatic cancer. Curr Opin Clin Nutr Metab Care 3:17–21

    Article  CAS  PubMed  Google Scholar 

  • Corominas-Faja B, Quirantes-Piné R, Oliveras-Ferraros C, Vazquez-Martin A, Cufí S, Martin-Castillo B, Micol V, Joven J, Segura-Carretero A, Menendez JA (2012) Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs. Aging 4:480–498

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cui Y, Andersen DK (2011) Pancreatogenic diabetes: special considerations for management. Pancreatology 11:279–294

    Article  PubMed  Google Scholar 

  • Currie CJ, Poole CD, Gale EA (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52:1766–1777

    Article  CAS  PubMed  Google Scholar 

  • Dalal S, Hui D, Bidaut L, Lem K, Del Fabbro E, Crane C, Reyes-Gibby CC, Bedi D, Bruera E (2012) Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manag 44:181–191

    Article  Google Scholar 

  • de Candia P, Minopoli G, Verga V, Gargiulo A, Vanoni M, Alberghina L (2011) Nutritional limitation sensitizes mammalian cells to GSK-3β inhibitors and leads to growth impairment. Am J Pathol 178:1814–1823

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Decensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S (2010) Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res 3:1451–1461

    Article  CAS  Google Scholar 

  • Deming D, Geiger P, Chen H, Kunnimalaiyaan M, Holen K (2010) ZM336372 induces apoptosis associated with phosphorylation of GSK-3beta in pancreatic adenocarcinoma cell lines. J Surg Res 161:28–32

    Article  CAS  PubMed  Google Scholar 

  • Ding XZ, Fehsenfeld DM, Murphy LO, Permert J, Adrian TE (2000) Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression. Pancreas 21:310–320

    Article  CAS  PubMed  Google Scholar 

  • Dong YW, Wang XP, Wu K (2009) Suppression of pancreatic carcinoma growth by activating peroxisome proliferator-activated receptor gamma involves angiogenesis inhibition. World J Gastroenterol 15:441–448

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ebrahimi B, Tucker SL, Li D, Abbruzzese JL, Kurzrock R (2004) Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101:2727–2736

    Article  CAS  PubMed  Google Scholar 

  • Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LA, Schrag D, Jamison PM, Jemal A, Wu XC et al (2005) Annual report to the nation on the status of cancer, 1975–2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407–1427

    Article  PubMed  Google Scholar 

  • Edwards CM, Edwards JR, Lwin ST, Esparza J, Oyajobi BO, McCluskey B, Munoz S, Grubbs B, Mundy GR (2008) Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo. Blood 111:2833–2842

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • El-Masry OS, Brown BL, Dobson PR (2012) Effects of activation of AMPK on human breast cancer cell lines with different genetic backgrounds. Oncol Lett 3:224–228

    CAS  PubMed  Google Scholar 

  • Farina AK, Bong YS, Feltes CM, Byers SW (2009) Post-transcriptional regulation of cadherin-11 expression by GSK-3 and beta-catenin in prostate and breast cancer cells. PLoS One 4:e4797

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Feng YH, Velazquez-Torres G, Gully C, Chen J, Lee MH, Yeung SC (2011) The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. J Cell Mol Med 15:825–836

    Article  CAS  PubMed  Google Scholar 

  • Ferla R, Haspinger E, Surmacz E (2012) Metformin inhibits leptin-induced growth and migration of glioblastoma cells. Oncol Lett 4:1077–1081

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fogar P, Pasquali C, Basso D, Sperti C, Panozzo MP, Tessari G, D’Angeli F, Del Favero G, Plebani M (1994) Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res 14:2827–2830

    CAS  PubMed  Google Scholar 

  • Fu Y, Zheng Y, Chan KG, Liang A, Hu F (2014) Lithium chloride decreases proliferation and migration of C6 glioma cells harboring isocitrate dehydrogenase 2 mutant via GSK-3β. Mol Biol Rep 41:3907–3913

    Article  CAS  PubMed  Google Scholar 

  • Galli A, Ceni E, Crabb DW, Mello T, Salzano R, Grappone C, Milani S, Surrenti E, Surrenti C, Casini A (2004) Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms. Gut 53:1688–1697

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Glaser B, Zoghlin G, Pienta K, Vinik AI (1988) PP response to secretin in obesity: effects of glucose intolerance. Horm Metab Res 20:288–292

    Article  CAS  PubMed  Google Scholar 

  • Gorkin RA, Richelson E (1979) Lithium ion accumulation by cultured glioma cells. Brain Res 171:365–368

    Article  CAS  PubMed  Google Scholar 

  • Gou S, Cui P, Li X, Shi P, Liu T, Wang C (2013) Low concentrations of metformin selectively inhibit CD133(+) cell proliferation in pancreatic cancer and have anticancer action. PLoS One 8:e63969

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gritti M, Würth R, Angelini M, Barbieri F, Peretti M, Pizzi E, Pattarozzi A, Carra E, Sirito R, Daga A, Curmi PM, Mazzanti M, Florio T (2014) Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current. Oncotarget 5:11252–11268

    Article  PubMed  PubMed Central  Google Scholar 

  • Grommes C, Conway DS, Alshekhlee A, Barnholtz-Sloan JS (2010) Inverse association of PPARγ agonists use and high grade glioma development. J Neurooncol 100:233–239

    Article  CAS  PubMed  Google Scholar 

  • Gustin JP, Karakas B, Weiss MB, Abukhdeir AM, Lauring J, Garay JP, Cosgrove D, Tamaki A, Konishi H, Konishi Y, Mohseni M, Wang G, Rosen DM, Denmeade SR, Higgins MJ, Vitolo MI, Bachman KE, Park BH (2009) Knockin of mutant PIK3CA activates multiple oncogenic pathways. Proc Natl Acad Sci USA 106:2835–2840

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hardie DG, Alessi DR (2013) LKB1 and AMPK and the cancer-metabolism link-ten years after. BMC Biol 11:36

    Article  PubMed  PubMed Central  Google Scholar 

  • Hong J, Samudio I, Liu S, Abdelrahim M, Safe S (2004) Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins. Endocrinology 145:5774–5785

    Article  CAS  PubMed  Google Scholar 

  • Hsieh MC, Lee TC, Cheng SM, Tu ST, Yen MH, Tseng CH (2012) The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res 2012:413782

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hsu C, Saif MW (2011) Diabetes and pancreatic cancer. In: Highlights from the “2011 ASCO Annual Meeting”, Chicago, IL, USA, June 3–7, 2011, JOP 12: 330–333

  • Hu M, Wu YS, Wu HW (1997) Effects of lithium deficiency in some insulin-sensitive tissues of diabetic Chinese hamsters. Biol Trace Elem Res 58(1–2):91–102

    Article  CAS  PubMed  Google Scholar 

  • Hu M, Wu Y, Wu H (1999) Influence of streptozotocin-induced diabetes in rats on the lithium content of tissue and the effect of dietary lithium supplements on this diabetic condition. Metabolism 48(5):558–563

    Article  CAS  PubMed  Google Scholar 

  • Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076–2083

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  • Jin HO, Hong SE, Woo SH, Lee JH, Choe TB, Kim EK, Noh WC, Lee JK, Hong SI, Kim JI, Park IC (2012) Silencing of twist1 sensitizes NSCLC cells to cisplatin via AMPK-activated mTOR inhibition. Cell Death Dis 3:e319

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Johnson JA, Bowker SL, Richardson K, Marra CA (2011) Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia 54:2263–2271

    Article  CAS  PubMed  Google Scholar 

  • Jung EJ, Lee KY, Lee BH (2012) Proliferating effect of orotic acid through mTORC1 activation mediated by negative regulation of AMPK in SK-Hep1 hepatocellular carcinoma cells. J Toxicol Sci 37:813–821

    Article  CAS  PubMed  Google Scholar 

  • Kaidanovich O, Eldar-Finkelman H (2002) The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Expert Opin Ther Targets 6(5):555–561

    Article  CAS  PubMed  Google Scholar 

  • Kandala PK, Srivastava SK (2012) Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling glucose regulatory protein 78 and AMPK. Oncotarget 3:435–449

    Article  PubMed  PubMed Central  Google Scholar 

  • Karnevi E, Said K, Andersson R, Rosendahl AH (2013) Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells. BMC Cancer 13:235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kawa S, Nikaido T, Unno H, Usuda N, Nakayama K, Kiyosawa K (2002) Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone. Pancreas 24:1–7

    Article  PubMed  Google Scholar 

  • Kawanami T, Takiguchi S, Ikeda N, Funakoshi A (2012) A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells. Oncol Rep 27:867–872

    CAS  PubMed  Google Scholar 

  • Kim MH, Kang KS (2012) Isoflavones as a smart curer for non-alcoholic fatty liver disease and pathological adiposity via ChREBP and Wnt signaling. Prev Med 54(Suppl):S57–S63

    Article  CAS  PubMed  Google Scholar 

  • Kisfalvi K, Eibl G, Sinnett-Smith J, Rozengurt E (2009) Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. Cancer Res 69:6539–6545

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kisfalvi K, Moro A, Sinnett-Smith J, Eibl G, Rozengurt E (2013) Metformin inhibits the growth of human pancreatic cancer xenografts. Pancreas 42:781–785

    Article  CAS  PubMed  Google Scholar 

  • Kliewer SA, Wilson TM (1998) The nuclear receptor PPARγ-bigger than fat. Curr Opin Genet Dev 8:576–581

    Article  CAS  PubMed  Google Scholar 

  • Ko AH, Tempero MA (2009) Personalized medicine for pancreatic cancer: a step in the right direction. Gastroenterology 136:43–45

    Article  PubMed  Google Scholar 

  • Koga H, Selvendiran K, Sivakumar R, Yoshida T, Torimura T, Ueno T, Sata M (2012) PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells. Int J Oncol 40:679–685

    CAS  PubMed  Google Scholar 

  • Korur S, Huber RM, Sivasankaran B, Petrich M, Morin P Jr, Hemmings BA, Merlo A, Lino MM (2009) GSK3beta regulates differentiation and growth arrest in glioblastoma. PLoS One 4:e7443

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Krentz AJ, Patel MB, Bailey CJ (2008) New drugs for type 2 diabetes mellitus: what is their place in therapy? Drugs 68:2131–2162

    Article  CAS  PubMed  Google Scholar 

  • Kudoh A, Satoh H, Hirai H, Watanabe T (2011) Pioglitazone upregulates adiponectin receptor 2 in 3T3-L1 adipocytes. Life Sci 88:1055–1062

    Article  CAS  PubMed  Google Scholar 

  • Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H (2007) Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Mol Cancer Ther 6:1151–1158

    Article  CAS  PubMed  Google Scholar 

  • Kurita M, Mashiko H, Rai M, Kumasaka T, Si Kouno, Si Niwa, Nakahata N (2002) Lithium chloride at a therapeutic concentration reduces Ca2+ response in protein kinase C down-regulated human astrocytoma cells. Eur J Pharmacol 442:17–22

    Article  CAS  PubMed  Google Scholar 

  • Kwan HT, Chan DW, Cai PC, Mak CS, Yung MM, Leung TH, Wong OG, Cheung AN, Ngan HY (2013) AMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activity. PLoS One 8:e53597

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee CW, Wong LL, Tse EY, Liu HF, Leong VY, Lee JM, Hardie DG, Ng IO, Ching YP (2012a) AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells. Cancer Res 72:4394–4404

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lee SY, Park SL, Hwang JT, Yi SH, Nam YD, Lim SI (2012b) Antidiabetic effect of Morinda citrifolia (Noni) fermented by Cheonggukjang in KK-A(y) diabetic mice. Evid Based Complement Alternat Med 2012:163280

    PubMed  PubMed Central  Google Scholar 

  • Lei P, Abdelrahim M, Cho SD, Liu X, Safe S (2008) Structure-dependent activation of endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer by 1,1-bis(3′-indoly)-1-(p-substituted phenyl)methanes. Mol Cancer Ther 7:3363–3372

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li D, Yeung SC, Hassan MM, Konopleva M, Abbruzzese JL (2009) Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 137:482–488

    Article  PubMed  PubMed Central  Google Scholar 

  • Li W, Yuan Y, Huang L, Qiao M, Zhang Y (2012) Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells. Diabetes Res Clin Pract 96:187–195

    Article  CAS  PubMed  Google Scholar 

  • Liao X, Zhang L, Thrasher JB, Du J, Li B (2003) Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer. Mol Cancer Ther 2:1215–1222

    CAS  PubMed  Google Scholar 

  • Liao X, Thrasher JB, Holzbeierlein J, Stanley S, Li B (2004) Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer. Endocrinology 145:2941–2949

    Article  CAS  PubMed  Google Scholar 

  • Liao KF, Lai SW, Li CI, Chen WC (2012) Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan. J Gastroenterol Hepatol 27:709–713

    Article  PubMed  Google Scholar 

  • Liu KJ, Lee YL, Yang YY, Shih NY, Ho CC, Wu YC, Huang TS, Huang MC, Liu HC, Shen WW, Leu SJ (2011) Modulation of the development of human monocyte-derived dendritic cells by lithium chloride. J Cell Physiol 226:424–433

    Article  CAS  PubMed  Google Scholar 

  • Liu YQ, Cheng X, Guo LX, Mao C, Chen YJ, Liu HX, Xiao QC, Jiang S, Yao ZJ, Zhou GB (2012) Identification of an annonaceous acetogenin mimetic, AA005, as an AMPK activator and autophagy inducer in colon cancer cells. PLoS One 7:e47049

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu X, Chhipa RR, Pooya S, Wortman M, Yachyshin S, Chow LM, Kumar A, Zhou X, Sun Y, Quinn B, McPherson C, Warnick RE, Kendler A, Giri S, Poels J, Norga K, Viollet B, Grabowski GA, Dasgupta B (2014) Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. Proc Natl Acad Sci USA 111:E435–E444

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lochhead PA, Coghlan M, Rice SQ, Sutherland C (2001) Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression. Diabetes 50(5):937–946

    Article  CAS  PubMed  Google Scholar 

  • Malik SA, Orhon I, Morselli E, Criollo A, Shen S, Mariño G, BenYounes A, Bénit P, Rustin P, Maiuri MC, Kroemer G (2011) BH3 mimetics activate multiple pro-autophagic pathways. Oncogene 30:3918–3929

    Article  CAS  PubMed  Google Scholar 

  • Maniati E, Bossard M, Cook N, Candido JB, Emami-Shahri N, Nedospasov SA, Balkwill FR, Tuveson DA, Hagemann T (2011) Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice. J Clin Investog 121:4685–4699

    Article  CAS  Google Scholar 

  • Martignoni ME, Kunze P, Hildebrandt W, Künzli B, Berberat P, Giese T, Klöters O, Hammer J, Büchler MW, Giese NA, Friess H (2005) Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia. Clin Cancer Res 11:5802–5808

    Article  CAS  PubMed  Google Scholar 

  • Melstrom LG, Melstrom KA Jr, Ding XZ, Adrian TE (2007) Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia. Histol Histopathol 22:805–814

    CAS  PubMed  Google Scholar 

  • Moh A, Zhang W, Yu S, Wang J, Xu X, Li J, Fu XY (2008) STAT3 sensitizes insulin signaling by negatively regulating glycogen synthase kinase-3 beta. Diabetes 57(5):1227–1235

    Article  CAS  PubMed  Google Scholar 

  • Morrison A, Li J (2011) PPAR-γ and AMPK–advantageous targets for myocardial ischemia/reperfusion therapy. Biochem Pharmacol 82:195–200

    Article  CAS  PubMed  Google Scholar 

  • Morrison A, Yan X, Tong C, Li J (2011) Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice. Am J Physiol Heart Circ Physiol 301:H895–H902

    Article  CAS  PubMed  Google Scholar 

  • Moses AG, Maingay J, Sangster K, Fearon KC, Ross JA (2009) Pro-inflammatory cytokine release by peripheral blood mononuclear cells from patients with advanced pancreatic cancer: relationship to acute phase response and survival. Oncol Rep 21:1091–1095

    CAS  PubMed  Google Scholar 

  • Motomura W, Nagamine M, Tanno S, Sawamukai M, Takahashi N, Kohgo Y, Okumura T (2004) Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells. J Gastroenterol 39:461–468

    Article  CAS  PubMed  Google Scholar 

  • Mouhieddine TH, Nokkari A, Itani MM, Chamaa F, Bahmad H, Monzer A, El-Merahbi R, Daoud G, Eid A, Kobeissy FH, Abou-Kheir W (2015) Metformin and ara-a effectively suppress brain cancer by targeting cancer stem/progenitor cells. Front Neurosci. doi:10.3389/fnins.2015.00442

    PubMed  PubMed Central  Google Scholar 

  • Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D (2012) Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res 14:R35

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nakajima A, Tomimoto A, Fujita K, Sugiyama M, Takahashi H, Ikeda I et al (2008) Inhibition of peroxisome proliferator-activated receptor gamma activity suppresses pancreatic cancer cell motility. Cancer Sci 99:1892–1900

    Article  CAS  PubMed  Google Scholar 

  • Nowicki MO, Dmitrieva N, Stein AM, Cutter JL, Godlewski J, Saeki Y, Nita M, Berens ME, Sander LM, Newton HB, Chiocca EA, Lawler S (2008) Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro Oncol 10:690–699

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ockenga J, Valentini L (2005) Review article: anorexia and cachexia in gastrointestinal cancer. Aliment Pharmacol Ther 22:583–594

    Article  CAS  PubMed  Google Scholar 

  • Ohira T, Gemmill RM, Ferguson K, Kusy S, Roche J, Brambilla E, Zeng C, Baron A, Bemis L, Erickson P, Wilder E, Rustgi A, Kitajewski J, Gabrielson E, Bremnes R, Franklin W, Drabkin HA (2003) WNT7a induces E-cadherin in lung cancer cells. Proc Natl Acad Sci USA 100:10429–10434

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ohta T, Elnemr A, Yamamoto M, Ninomiya I, Fushida S, Nishimura G, Fujimura T, Kitagawa H, Kayahara M, Shimizu K, Yi S, Miwa K (2002) Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, modulates the E-cadherin/beta-catenin system in a human pancreatic cancer cell line, BxPC-3. Int J Oncol 21:37–42

    CAS  PubMed  Google Scholar 

  • Papi A, Tatenhorst L, Terwel D, Hermes M, Kummer MP, Orlandi M, Heneka MT (2009) PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models. J Neurochem 109:1779–1790

    Article  CAS  PubMed  Google Scholar 

  • Park JB, Lee MS, Cha EY, Lee JS, Sul JY, Song IS, Kim JY (2012) Magnolol-induced apoptosis in HCT-116 colon cancer cells is associated with the AMP-activated protein kinase signaling pathway. Biol Pharm Bull 35:1614–1620

    Article  CAS  PubMed  Google Scholar 

  • Pausch T, Hartwig W, Hinz U, Swolana T, Bundy BD, Hackert T, Grenacher L, Büchler MW, Werner J (2012) Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancer. Surgery 152(3 Suppl 1):S81–S88

    Article  PubMed  Google Scholar 

  • Peng Z, Ji Z, Mei F, Lu M, Ou Y, Cheng X (2013) Lithium inhibits tumorigenic potential of PDA cells through targeting hedgehog-GLI signaling pathway. PLoS One 8:e61457

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Pérez-Ortiz JM, Tranque P, Burgos M, Vaquero CF, Llopis J (2007) Glitazones induce astroglioma cell death by releasing reactive oxygen species from mitochondria: modulation of cytotoxicity by nitric oxide. Mol Pharmacol 72:407–417

    Article  PubMed  CAS  Google Scholar 

  • Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnquist HJ, Larsson J (1993) Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 80:1047–1050

    Article  CAS  PubMed  Google Scholar 

  • Qin B, Anderson RA (2012) An extract of chokeberry attenuates weight gain and modulates insulin, adipogenic and inflammatory signalling pathways in epididymal adipose tissue of rats fed a fructose-rich diet. Br J Nutr 108:581–587

    Article  CAS  PubMed  Google Scholar 

  • Rasouli N, Kern PA, Elbein SC, Sharma NK, Das SK (2012) Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts. Pharmacogenet Genomics 22:484–497

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reiser G, Duhm J (1982) Transport pathways for lithium ions in neuroblastoma × glioma hybrid cells at ‘therapeutic’ concentrations of Li. Brain Res 252:247–258

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez-Gil JE, Guinovart JJ, Bosch F (1993) Lithium restores glycogen synthesis from glucose in hepatocytes from diabetic rats. Arch Biochem Biophys 301(2):411–415

    Article  CAS  PubMed  Google Scholar 

  • Rossetti L (1989) Normalization of insulin sensitivity with lithium in diabetic rats. Diabetes 38(5):648–652

    Article  CAS  PubMed  Google Scholar 

  • Rossetti L, Giaccari A, Klein-Robbenhaar E, Vogel LR (1990) Insulinomimetic properties of trace elements and characterization of their in vivo mode of action. Diabetes 39(10):1243–1250

    Article  CAS  PubMed  Google Scholar 

  • Sakamoto A, Hongo M, Saito K, Nagai R, Ishizaka N (2012) Reduction of renal lipid content and proteinuria by a PPAR-γ agonist in a rat model of angiotensin II-induced hypertension. Eur J Pharmacol 682:131–136

    Article  CAS  PubMed  Google Scholar 

  • Saneto RP, Perez-Polo JR (1982) Differences in the accumulation of lithium in human neuroblastoma and glioma cells in tissue culture. J Neurosci Res 7:413–418

    Article  CAS  PubMed  Google Scholar 

  • Sanli T, Linher-Melville K, Tsakiridis T, Singh G (2012) Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells. PLoS One 7:e32035

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sasaki T, Fujimoto Y, Tsuchida A, Kawasaki Y, Kuwada Y, Chayama K (2001) Activation of peroxisome proliferator-activated receptor gamma inhibits the growth of human pancreatic cancer. Pathobiology 69:258–265

    Article  CAS  PubMed  Google Scholar 

  • Sato A, Sunayama J, Okada M, Watanabe E, Seino S, Shibuya K, Suzuki K, Narita Y, Shibui S, Kayama T, Kitanaka C (2012) Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK. Stem Cells Transl Med 1(11):811–824

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sawai H, Liu J, Reber HA, Hines OJ, Eibl G (2006) Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system. Mol Cancer Res 4:159–167

    Article  CAS  PubMed  Google Scholar 

  • Seliger C, Meyer AL, Renner K, Leidgens V, Moeckel S, Jachnik B, Dettmer K, Tischler U, Gerthofer V, Rauer L, Uhl M, Proescholdt M, Bogdahn U, Riemenschneider MJ, Oefner PJ, Kreutz M, Vollmann-Zwerenz A, Hau P (2016) Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2. Cell Cycle. doi:10.1080/15384101.2016.1186316

    PubMed  Google Scholar 

  • Sesen J, Dahan P, Scotland SJ, Saland E, Dang VT, Lemarié A, Tyler BM, Brem H, Toulas C, Cohen-Jonathan Moyal E, Sarry JE, Skuli N (2015) Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response. PLoS One 10:e0123721. doi:10.1371/journal.pone.0123721

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Shi WY, Xiao D, Wang L, Dong LH, Yan ZX, Shen ZX, Chen SJ, Chen Y, Zhao WL (2012) Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell Death Dis 3:e275

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Shimazaki N, Togashi N, Hanai M, Isoyama T, Wada K, Fujita T, Fujiwara K, Kurakata S (2008) Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model. Eur J Cancer 44:1734–1743

    Article  CAS  PubMed  Google Scholar 

  • Shiota A, Shimabukuro M, Fukuda D, Soeki T, Sato H, Uematsu E, Hirata Y, Kurobe H, Maeda N, Sakaue H, Masuzaki H, Shimomura I, Sata M (2012) Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice. Cardiovasc Diabetol 11:139

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sinnett-Smith J, Kisfalvi K, Kui R, Rozengurt E (2013) Metformin inhibition of mTORC1 activation, DNA synthesis and proliferation in pancreatic cancer cells: dependence on glucose concentration and role of AMPK. Biochem Biophys Res Commun 430:352–357

    Article  CAS  PubMed  Google Scholar 

  • Siriwardhana N, Kalupahana NS, Cekanova M, LeMieux M, Greer B, Moustaid-Moussa N (2013) Modulation of adipose tissue inflammation by bioactive food compounds. J Nutr Biochem 24:613–623

    Article  CAS  PubMed  Google Scholar 

  • Sjöholm A (1996) Lithium stimulation of rat pancreatic beta-cell replication is mediated through pertussis toxin-sensitive GTP-binding proteins and occurs independently of Ca2+ influx, cAMP, or protein kinase C activation. Diabetes 45(8):1057–1062

    Article  PubMed  Google Scholar 

  • Skorokhod A, Bachmann J, Giese NA, Martignoni ME, Krakowski-Roosen H (2012) Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexia. BMC Cancer 12:265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Slezak LA, Andersen DK (2001) Pancreatic resection: effects on glucose metabolism. World J Surg 25:452–460

    Article  CAS  PubMed  Google Scholar 

  • Song CW, Lee H, Dings RP, Williams B, Powers J, Santos TD, Choi BH, Park HJ (2012) Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells. Sci Rep 2:362

    PubMed  PubMed Central  Google Scholar 

  • Soranna D, Scotti L, Zambon A, Bosetti C, Grassi G, Catapano A, La Vecchia C, Mancia G, Corrao G (2012) Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist 17:813–822

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Soraya H, Esfahanian N, Shakiba Y, Ghazi-Khansari M, Nikbin B, Hafezzadeh H, Maleki Dizaji N, Garjani A (2012) Anti-angiogenic effects of metformin, an AMPK activator, on human umbilical vein endothelial cells and on granulation tissue in rat. Iran J Basic Med Sci 15:1202–1209

    CAS  PubMed  PubMed Central  Google Scholar 

  • Soritau O, Tomuleasa C, Aldea M, Petrushev B, Susman S, Gheban D, Ioani H, Cosis A, Brie I, Irimie A, Kacso G, Florian IS (2011) Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas. J BUON 16:282–289

    CAS  PubMed  Google Scholar 

  • Srivastava P, Saxena AK, Kale RK, Baquer NZ (1993) Insulin like effects of lithium and vanadate on the altered antioxidant status of diabetic rats. Res Commun Chem Pathol Pharmacol 80:283–293

    CAS  PubMed  Google Scholar 

  • Stevens RJ, Roddam AW, Beral V (2007) Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis. Br J Cancer 96:507–509

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sul YH, Lee MS, Cha EY, Thuong PT, Khoi NM, Song IS (2013) An ent-kaurane diterpenoid from Croton tonkinensis induces apoptosis by regulating AMP-activated protein kinase in SK-HEP1 human hepatocellular carcinoma cells. Biol Pharm Bull 36:158–164

    Article  CAS  PubMed  Google Scholar 

  • Sun WH, Chen GS, Ou XL, Yang Y, Luo C, Zhang Y, Shao Y, Xu HC, Xiao B, Xue YP, Zhou SM, Zhao QS, Ding GX (2009) Inhibition of COX-2 and activation of peroxisome proliferator-activated receptor gamma synergistically inhibits proliferation and induces apoptosis of human pancreatic carcinoma cells. Cancer Lett 275:247–255

    Article  CAS  PubMed  Google Scholar 

  • Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A (2011) Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis. Liver Int 31:1285–1297

    Article  CAS  PubMed  Google Scholar 

  • Tabata I, Schluter J, Gulve EA, Holloszy JO (1994) Lithium increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes 43(7):903–907

    Article  CAS  PubMed  Google Scholar 

  • Takeuchi Y, Takahashi M, Sakano K, Mutoh M, Niho N, Yamamoto M, Sato H, Sugimura T, Wakabayashi K (2007) Suppression of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliferator-activated receptor gamma. Carcinogenesis 28:1692–1696

    Article  CAS  PubMed  Google Scholar 

  • Tapia-Pérez JH, Kirches E, Mawrin C, Firsching R, Schneider T (2011) Cytotoxic effect of different statins and thiazolidinediones on malignant glioma cells. Cancer Chemother Pharmacol 67:1193–1201

    Article  PubMed  CAS  Google Scholar 

  • Ucbek A, Ozünal ZG, Uzun O, Gepdıremen A (2014) Effect of metformin on the human T98G glioblastoma multiforme cell line. Exp Ther Med 7:1285–1290

    CAS  PubMed  PubMed Central  Google Scholar 

  • Uomo G, Gallucci F, Rabitti PG (2006) Anorexia-cachexia syndrome in pancreatic cancer: recent development in research and management. JOP 7:157–162

    PubMed  Google Scholar 

  • Vestergaard P, Schou M (1987) Does long-term lithium treatment induce diabetes mellitus? Neuropsychobiology 17:130–132

    Article  CAS  PubMed  Google Scholar 

  • Vitale G, Zappavigna S, Marra M, Dicitore A, Meschini S, Condello M, Arancia G, Castiglioni S, Maroni P, Bendinelli P, Piccoletti R, van Koetsveld PM, Cavagnini F, Budillon A, Abbruzzese A, Hofland LJ, Caraglia M (2012) The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. Biotechnol Adv 30:169–184

    Article  CAS  PubMed  Google Scholar 

  • Wang LW, Li ZS, Zou DW, Jin ZD, Gao J, Xu GM (2008a) Metformin induces apoptosis of pancreatic cancer cells. World J Gastroenterol 14:7192–7198

    Article  CAS  PubMed  Google Scholar 

  • Wang JS, Wang CL, Wen JF, Wang YJ, Hu YB, Ren HZ (2008b) Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest. World J Gastroenterol 14:3982–3989

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Welch MR, Grommes C (2013) Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients. CNS Oncol 2:237–246

    Article  CAS  PubMed  Google Scholar 

  • Wong WT, Tian XY, Xu A, Yu J, Lau CW, Hoo RL, Wang Y, Lee VW, Lam KS, Vanhoutte PM, Huang Y (2011) Adiponectin is required for PPARγ-mediated improvement of endothelial function in diabetic mice. Cell Metab 14:104–115

    Article  CAS  PubMed  Google Scholar 

  • Würth R, Pattarozzi A, Gatti M, Bajetto A, Corsaro A, Parodi A, Sirito R, Massollo M, Marini C, Zona G, Fenoglio D, Sambuceti G, Filaci G, Daga A, Barbieri F, Florio T (2013) Metformin selectively affects human glioblastoma tumor-initiating cell viability: a role for metformin-induced inhibition of Akt. Cell Cycle 12:145–156

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yu HC, Lin CS, Tai WT, Liu CY, Shiau CW, Chen KF (2013) Nilotinib induces autophagy in hepatocellular carcinoma through AMPK activation. J Biol Chem 288:18249–18259

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yu Z, Zhao G, Xie G, Zhao L, Chen Y, Yu H, Zhang Z, Li C, Li Y (2015) Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo. Oncotarget 6:32930–32943

    PubMed  PubMed Central  Google Scholar 

  • Zang C, Wächter M, Liu H, Posch MG, Fenner MH, Stadelmann C, von Deimling A, Possinger K, Black KL, Koeffler HP, Elstner E (2003) Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas. J Neurooncol 65:107–118

    Article  PubMed  Google Scholar 

  • Zhang F, Phiel CJ, Spece L, Gurvich N, Klein PS (2003) Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. J Biol Chem 278:33067–33077

    Article  CAS  PubMed  Google Scholar 

  • Zhang P, Li H, Tan X, Chen L, Wang S (2013) Association of metformin use with cancer incidence and mortality: a meta-analysis. Cancer Epidemiol 37:207–218

    Article  PubMed  CAS  Google Scholar 

  • Zhu H, Han B, Pan X, Qi H, Xu L (2012) Thiazolidenediones induce tumour-cell apoptosis through the Akt-GSK3β pathway. J Clin Pharm Ther 37:65–70

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Memorial Hospital, Istanbul, Turkey

    İlhan Elmaci

  2. Neuroacademy Group, Istanbul, Turkey

    İlhan Elmaci

  3. Department of Immunology, Experimental Medicine Research Center, Istanbul, Turkey

    Meric A Altinoz

Authors
  1. İlhan Elmaci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meric A Altinoz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meric A Altinoz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Elmaci, İ., Altinoz, M.A. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme. Biochem Genet 54, 573–618 (2016). https://doi.org/10.1007/s10528-016-9754-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10528-016-9754-9

Keywords

Search

Navigation